According to Altimmune's latest financial reports the company has $0.19 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $0.18 B | -6.95% |
2021-12-31 | $0.19 B | -11.84% |
2020-12-31 | $0.22 B | 396.21% |
2019-12-31 | $45.52 M | -5.78% |
2018-12-31 | $48.31 M | -0.75% |
2017-12-31 | $48.67 M | 51.14% |
2016-12-31 | $32.2 M | 93.45% |
2015-12-31 | $16.64 M | -8.89% |
2014-12-31 | $18.27 M | 149.11% |
2013-12-31 | $7.33 M | -37.16% |
2012-12-31 | $11.67 M | -26.36% |
2011-12-31 | $15.85 M | 29.82% |
2010-12-31 | $12.21 M | 287.35% |
2009-12-31 | $3.15 M | -83.38% |
2008-12-31 | $18.96 M | -53.26% |
2007-12-31 | $40.57 M | -2292.98% |
2006-12-31 | $-1.86 M | -103.3% |
2005-12-31 | $56.09 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 615.73% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $10.67 M | -94.50% | ๐บ๐ธ USA |